NaveenKellaMD
Urology • San Antonio, TXMale Sexual Dysfunction, Minimally Invasive Surgery, Surgical Oncology
Founder, The Urology Place
Dr. Kella is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9618 Huebner Rd
# ST120
San Antonio, TX 78240Phone+1 210-617-3670Fax+1 888-316-9464
Education & Training
Baylor College of MedicineFellowship, Urologic Surgical Oncology, 2004
Tufts Medical CenterResidency, Urology, 2003
St Elizabeth's Medical Center/Lemuel Shattuck HospitalInternship, Transitional Year, 1998 - 1999
University of Texas Southwestern Medical SchoolClass of 1998
Stanford UniversityBS, Chemical Engineering, 1990 - 1994
Certifications & Licensure
TX State Medical License 2003 - 2026
NY State Medical License 2003 - 2005- American Board of Urology Urology
Awards, Honors, & Recognition
- Top Doctors:SE Texas Castle Connolly, 2013
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
- Super Doctor SuperDoctors.com
- Join now to see all
Clinical Trials
- Performance Evaluation of the AMS CONTINUUM™ Device Start of enrollment: 2009 May 01
- Positive Imaging Study for Distant Metastases in Patients With Castration-Resistant Prostate Cancer Start of enrollment: 2012 Jan 01
- A Comparison of TULSA Procedure vs. Radical Prostatectomy in Participants With Localized Prostate Cancer Start of enrollment: 2021 Nov 01
Roles: Principal Investigator, Contact
- Join now to see all
Publications & Presentations
PubMed
- 49 citationsImpact of the Cell Cycle Progression Test on Physician and Patient Treatment Selection for Localized Prostate CancerNeal D. Shore, Naveen Kella, Brian J. Moran, Judd Boczko, Fernando J. Bianco
The Journal of Urology. 2016-03-01 - 31 citationsInfluence of a genomic classifier on post-operative treatment decisions in high-risk prostate cancer patients: results from the PRO-ACT study.Steven N. Michalopoulos, Naveen Kella, Ryan Payne, Paulos Yohannes, Amar Singh
Current Medical Research and Opinion. 2014-05-06 - 42 citationsEffect of a genomic classifier test on clinical practice decisions for patients with high-risk prostate cancer after surgeryKetan K. Badani, Darby J. S. Thompson, Gordon D. Brown, Daniel Holmes, Naveen Kella
BJU International. 2015-03-01
Journal Articles
- A Parallel Randomized Clinical Trial Examining the Return of Urinary Continence After Robot-Assisted Radical Prostatectomy with or Without a Small Intestinal Submucosa...Naveen Kella, Michelle A Boger, Michael O Koch, Steven M Lucas, Chandru P Sundaram, Clinton D Bahler, Thomas A Gardner, The Journal of Urology
Press Mentions
Creative Medical Technology to Showcase CaverStem® at American Urological Association Annual Meeting - Largest and Most Prominent Gathering of Urologists in the WorldApril 12th, 2022- Leading Urologist Doubles down on CaverStem® Regenerative Stem Cell Procedure for Treatment of Erectile Dysfunction in MenJanuary 20th, 2021
- Francis Medical Announces First Patient Treated in VAPOR 2 Pivotal Study for Water Vapor Ablation of Prostate CancerJuly 20th, 2023
- Join now to see all
Other Languages
- Spanish
External Links
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
